Tag: HRS 2019
HRS 2019: No “home run superiority” for His-CRT compared with biventricular...
Roderick Tung (Chicago, USA) talks to BLearning Cardio about the results of the His-SYNC trial which he presented at HRS 2019.
The His-SYNC trial set out to...
HRS 2019: Rotational TLE can be used “as a first-line tool...
Christoph Starck (Berlin, Germany) and Saumya Sharma (Houston, USA) discuss the benefits of using rotational transvenous lead extraction (TLE) tools. Starck and Sharma note...
HRS 2019: MADIT trials analysis shows decline in sudden cardiac deaths...
Valentina Kutyifa (Rochester, USA) discusses the late-breaking study findings looking at data from the family of MADIT (Multicenter Automatic Defibrillator) trials.
Kutyifa told Cardiac Rhythm...
HRS 2019: Next-gen cryoballoon ablation system provides “greater personalisation” to operators
Ante Anic (Split, Croatia) discusses the first in-human trial (CRYO-FIM) looking at a novel cryoballoon ablation system for pulmonary vein isolation at HRS 2019...
REAFFIRM trial data show no significant difference between rotor ablation and...
Johannes Brachmann (Coburg, Germany) speaks to Cardiac Rhythm News at HRS 2019 about the REAFFIRM trial, which compared the use of rotor ablation versus...
UNTOUCHED finds high conversion efficacy and low adverse event rate for...
The Emblem subcutaneous implantable defibrillator system (S-ICD; Boston Scientific) demonstrated a high conversion efficacy and low adverse event rate. Data from the UNTOUCHED trial...
HRS 2019: Ear clip uses neurostimulation to effectively reduce AFib burden
A trial evaluating Parasym’s neurostimulation technology shows that an ear-clip-like device can help reduce atrial fibrillation burden. The results were presented at the Heart...
Low referral rates and treatment disparities lead to underuse of ICDs...
Implantable cardiac devices are underused, with widespread gender and race treatment disparities, and low referral rates to electrophysiologists, according to the findings from three...